Where innovative Medical Go-To-Market Success is the rule! 

Want to Learn or See More? Click here

Synergistic Marketing, founded in 1990 by Mark Lutvak, is a successful, growing and profitable sales and marketing contracting firm and consultancy. We are dedicated to serving Small Emerging businesses that own or possess Medical Technology or Medical Device IP. We support our clients with a go-to-market strategy that takes advantage of our extensive network of medical industry companies as well as our extensive list of contacts who are our Corporate Partners.

Want to Learn or See More? Click here


Medical Technology and Device News Title

  • December 16, 2014:

    Olympus announced on Monday FDA 510(k) clearance of Narrow Band Imaging® (NBI) as enabling effective targeting of biopsies not seen under white light and improved visualization of tumor boundaries in Non-Muscle-Invasive Bladder Cancer (NMIBC) patients. The FDA clearance provides new treatment opportunities for urologists both in-office and in the O.R. Additionally, it offers the potential for improved cost reduction and better patient outcomes resulting from earlier detection.Full Story

  • December 15, 2014:

    Researchers at Tufts University in Massachusetts and the University of Illinois have invented a newly Invented Implant that Uses Wireless Signal which can play a major role in the treatment of infections. Several implants can be activated at once in the body to do away with bacterial infections. The implants use heat to treat infected tissue. In an experiment with mice infected with staphylococcus the treatment worked so effectively the mice showed absolutely no sign of the bacteria afterwards.Full Story

  • December 12, 2014:

    The Empatica team, led by Massachusetts Institute of Technology (MIT) professor Dr. Rosalind W. Picard, began work on a wearable device that measures emotions, including stress back in 2007. The device can also predict seizures. Emaptica teamed up with Pearl Studios to create a thin and attractive smartwatch that everyone will want to wear. It comes in multiple sizes, including one for children, many of whom often suffer from severe seizures.Full Story

  • December 9, 2014:

    Stimwave Technologies Incorporated has received FDA clearance to market the world’s first wireless, micro-technology neuro-modulation device for relief of chronic back and leg pain. The technology, developed by scientists and engineers led by co-inventor and Chairman Laura Tyler Perryman, uses a tiny injectable microchip device that delivers small pulses of energy to electrodes near surrounding nerves, triggering a reaction that enables the brain to remap specific pain signals, thus providing pain relief. Currently being marketed throughout Europe, the device will be commercially available in the U.S. as of January 2015.Full Story

  • December 5, 2014:

    Every year there are 1.8 million new cases of bloodstream infection in the U.S. and Europe, causing patients serious complications and imposing a high cost burden on health care systems.
    “CRE (Carbapenem-Resistant Enterobacteriaceae ) bloodstream infections have an average mortality rate of 50% due to the total lack of effective antibiotics. With fewer anti-infective drugs being developed, and the continuing emergence of drug-resistant pathogens, clinicians need new tools to fight bloodstream infections,” said Bob Ward, CEO, ExThera Medical.
    Since 2008, privately funded ExThera (short for Extracorporeal Therapy) has been developing these tools. ExThera’s Seraph ® Microbind ® Affinity Blood Filter (Seraph), now fully developed and about to enter clinical trials, is a broad-spectrum ‘hemoperfusion’ device with demonstrated ability to bind and remove a long list of disease-causing agents.Full Story

  • December 3, 2014:

    A study presented at the annual meeting of the Radiological Society of North America (RSNA) has shown changes in brain connections could be an early biomarker of Alzheimer’s Disease. Jeffrey W. Prescott, MD, PhD, radiology resident at Duke University Medical Center and his team used diffusion tensor imaging (DTI) to look at the structural connectome, a map of white matter tracts that carry signals between different areas of the brain.
    “We have findings that suggest there are early changes in the brain which we can detect with imaging that can help identify patients who are developing early Alzheimer’s and may benefit from early treatment,” Prescott.Full Story

  • December 1, 2014:

    Johns Hopkins Medicine researchers published study results in the Nov. 17 issue of Proceedings of the National Academy of Sciences showing that light can affect blood vessels. “If we can develop novel ways of delivering light to blood vessels, this molecular switch for relaxation could be harnessed in all types of vascular disease treatment,” says senior author Dan Berkowitz, M.D., of the Johns Hopkins University departments of Anesthesiology and Critical Care Medicine and of Biomedical Engineering.Full Story

  • November 23, 2014:

    Researchers from North Carolina State University have developed a technique that allows ultrasound to penetrate bone or metal, using customized structures that offset the distortion usually caused by these so-called “aberrating layers.” The technique can be used for ultrasound imaging, as well as therapeutically – such as using ultrasound to apply energy to brain tumors, in order to burn them. Furthermore, “These metamaterials could also be used in industrial settings,” says Dr. Yun Jing, an assistant professor of mechanical and aerospace engineering at NC State and senior author of the paper. “For example, it would allow you to use ultrasound to detect cracks in airplane wings under the wing’s metal ‘skin.’”.
    Full Story